27.08.2014 • Newsautomotive coatingsAxaltaCarlyle Group

IPO in Sight for Former DuPont Automotive Coatings

US paints and coatings maker Axalta Coating Systems, the former automotive coatings business of DuPont, is planning an initial public offering (ipo), according to a filing with the regulatory authority US Securities and Exchange Commission.

The company, currently owned to 95% by private equity investor Carlyle Group, has not yet revealed the timing of the stock launch or details of pricing and the number of shares to be floated.  However, the news agency Reuters said banks hired by Carlyle to handle the transaction are expecting to raise up to $1.6 billion.

Citigroup, Goldman Sachs, Deutsche Bank, and J.P. Morgan are listed as book runners, along with BofA Merrill Lynch, Barclays, Credit Suisse and Morgan Stanley.

Axalta said it intends to use any net proceeds from the offering, plus cash on hand, to pay down debt.

Based in Philadelphia, the former DuPont business makes liquid and powder coatings for the automotive and general transportation industries. It operates 35 manufacturing centers and does business in more than 130 countries.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.